Pharmstandard International S.A., 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 55,224 shares at $4.57 ($252K) on 2016-08-24, disclosed to the SEC on 2016-08-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ARGS | BUY | 2016-09-07 | $162K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |
| ARGS | BUY | 2016-08-23 | $320K | — | Filing → |